Showing results (21-30 of 173) with videos related to
Sort By:
Pageof 18
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 10, 2014
The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitusIchiro Wakabayashi, Takashi DaimonLipids in Health and Disease|July 29, 2019
Comparison of discrimination for cardio-metabolic risk by different cut-off values of the ratio of triglycerides to HDL cholesterolIchiro Wakabayashi, Takashi DaimonHeadache|May 15, 2021
Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patientsFumihiko Sakai, Takao Takeshima, Gosuke Homma, et al.Diabetes, Obesity & Metabolism|August 25, 2023
Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY)Daisuke Yabe, Kosuke Shiki, Gosuke Homma, et al.Lipids in Health and Disease|May 16, 2019
Proneness to high blood lipid-related indices in female smokersYuri Chimura, Takashi Daimon, Ichiro WakabayashiStatistics in Medicine|June 4, 2015
An extension of Bayesian predictive sample size selection designs for monitoring efficacy and safetySatoshi Teramukai, Takashi Daimon, Sarah ZoharStatistics in Medicine|July 19, 2012
A Bayesian predictive sample size selection design for single-arm exploratory clinical trialsSatoshi Teramukai, Takashi Daimon, Sarah ZoharJournal of Pharmacokinetics and Pharmacodynamics|December 8, 2006
Assessing nonlinearity in compartment models via the relative curvature measureTakashi Daimon, Hiroshi Yamada, Masashi GotoWomen'S Health Reports (New Rochelle, N.Y.)|October 24, 2025
Gender Differences in the Associations Between Serum Urate and Cardiometabolic Risk Factors in Age-Matched Middle-Aged JapaneseIchiro Wakabayashi, Takashi Daimon, Tetsuya YamamotoPharmaceutical Statistics|September 10, 2019
Bayesian sample-size determination methods considering both worthwhileness and unpromisingness for exploratory two-arm randomized clinical trials with binary endpointsTomoyuki Kakizume, Fanghong Zhang, Yohei Kawasaki, et al.Pageof 18